Daily Vibration Therapy for Hand Nerve Damage from Cancer
Daily Hand-Held Vibration Therapy
Recruiting
N/A
Interventional Study
Neuropathy
Cancer
Chemotherapeutic Drug - Induced Nephropathy
Chemotherapeutic Toxicity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 16 (estimated)
- Sponsor
- Indiana University · Other
Who this trial is looking for
This trial is looking for adults who have experienced nerve damage in their hands from chemotherapy. Participants will use a hand-held vibrating device for three minutes each day to see if it helps reduce their symptoms.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years or older.
- I can provide informed consent.
- I completed chemotherapy at least 60 days ago.
- I was treated with specific neurotoxic chemotherapy drugs.
- I have ongoing hand nerve damage rated as Grade 2 or higher.
- I have non-metastatic solid tumor cancer.
- I agree to return to the clinic for measurements.
You may not be able to join if
- I have a different condition causing hand neuropathy.
- I have diabetes.
- I have known issues that prevent me from using vibration therapy.
- I am receiving radiation therapy for my upper body.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this pilot study is to determine the safety and feasibility of a daily 3-minute hand-held vibration therapy intervention to reduce the severity of CIPN in the hands. The investigators hypothesize that daily vibration therapy can reduce the severity of patient's CIPN in their hands and improve CIPN-related quality of life. The hope is that results from this study will provide early d…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. 18 years or older at enrollment
2. Able to provide informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
3. Have completed chemotherapy ≥ 60 days prior to enrollment
4. Were exposed to neurotoxic chemotherapy with one or more of the fo…
Contacts